Objective To systematically analyze the medical radiation exposure levels in a district of Ningbo City and to provide a scientific basis for the reasonable and effective control of medical radiation exposure. Methods Based on the radiological diagnosis frequency and dose information system, basic medical radiation exposure data were collected, such as radiation doses received by patients in various X-ray diagnostic examinations, from all 13 public medical institutions in a district of Ningbo City from January 1 to December 31, 2020. The data were analyzed for the percentage and collective effective dose of various diagnostic examinations, the distribution of examinations by sex and age, and the number of patients undergoing two or more examinations and their cumulative doses within multiple time intervals. Results Among medical X-ray diagnostic examinations in the district, the percentages of CT examination and routine photography examination were 50.88% and 47.93%, respectively, and the collective effective dose of CT examination accounted for 97.75%. By age and sex, the frequency of examination was the highest in the age group of 45-54 years, and the frequency of examination in the male was higher than that in the female before age 55. The annual effective dose for two patients exceeded 100 mSv. Conclusion In this study, CT examination accounted for up to 50.88% of all medical X-ray diagnostic examinations, and contributed 97.75% of the collective effective dose, highlighting the need for particular attention to the justification of medical radiation exposure from CT.

Objective:To investigate the correlation between metabolic syndrome (MS), its different components and the risk of cholecystolithiasis and gallbladder polyp in Uygur population in rural areas of southern Xinjiang.Methods:This study was a prospective cohort study. A baseline survey was conducted in August 2016. A typical sampling method was used to select 10 476 Uygur people in rural areas of southern Xinjiang as the research objects. Baseline clinical data were collected, including demographic data such as age, gender, and education level, and laboratory examination indicators such as blood glucose and triglyceride levels. According to the MS diagnostic criteria of the relevant guidelines, 10 476 subjects were divided into the MS group (3 475 cases) and the non-MS group (7 001 cases). The incidence of cholecystolithiasis and gallbladder polyp was followed up in 2019, 2021 and 2023, respectively. Cox regression was used to analyze the correlation between MS, its different components and the risk of cholecystolithiasis and gallbladder polyp. Chi-square test and independent sample t test were used for statistical analysis. Results:The median follow-up time was 6.43 years in 10 476 subjects, and the overall cumulative incidence of cholecystolithiasis and gallbladder polyp was 5.43% (569/10 476). The cumulative incidence of cholecystolithiasis and gallbladder polyp in the MS group was 10.73% (373/ 3 475), which was significantly higher than that in the non-MS group (2.80% (196/7 001)); χ2= 284.62, P<0.001). The results of multivariate Cox regression analysis showed that, 41 to 59 years old ( HR=1.26, 95% confidence interval (95% CI): 1.03 to 1.54, P=0.025), ≥60 years old ( HR=1.88, 95% CI: 1.45 to 2.45, P<0.001), female ( HR=1.34, 95% CI: 1.13 to 1.60, P=0.001), MS ( HR=2.19, 95% CI: 1.59 to 3.01, P<0.001), hypertriglyceridemia ( HR=1.47, 95% CI: 1.18 to 1.83, P=0.001), hypertension ( HR=1.30, 95% CI: 1.04 to 1.62, P=0.023), and hyperglycemia ( HR=1.24, 95% CI: 1.01 to 1.52, P=0.041) were independent risk factors for cholecystolithiasis and gallbladder polyp. After the adjustment of age and gender, MS ( HR=3.39, 95% CI: 2.82 to 4.07, P<0.001), hypertriglyceridemia ( HR=2.37, 95% CI: 2.00 to 2.81, P<0.001), hypertension ( HR=2.00, 95% CI: 1.66 to 2.41, P<0.001), and hyperglycemia ( HR=1.86, 95% CI: 1.55 to 2.23, P<0.001) were still correlated with cholecystolithiasis and gallbladder polyp, and there was the srtongest correlation between MS and cholecystolithiasis and gallbladder polyp. The results of univariate Cox regression analysis showed that along with the increase of accumulated of MS components, the risk of cholecystolithiasis and gallbladder polyp significantly increased (1 to 5 components corresponding HR (95% CI) were 1.92 (1.13 to 3.24), 2.21 (1.32 to 3.69), 6.91 (4.22 to 11.30), 8.56 (5.15 to 14.22), and 10.73 (5.66 to 20.33); P=0.015, =0.002, <0.001, <0.001, and <0.001); after age and gender were adjusted, this trend still existed (1 to 5 components corresponding HR (95% CI) were 1.81(1.07 to 3.06), 1.95(1.16 to 3.27), 5.64(3.42 to 9.32), 6.69(3.97 to 11.25), and 7.76(4.04 to 14.91); P=0.028, =0.012, <0.001, <0.001, and <0.001). Conclusion:MS and its components can increase the risk of cholecystolithiasis and gallbladder polyp, and the risk of cholecystolithiasis and gallbladder polyp significantly increases along with the increase of accumulated of MS components.

Objective:To explore the safety and efficacy of computed tomography (CT) guided percutaneous interstitial brachytherapy in the treatment of recurrent cervical cancer with isolated lesions in the radiated field.Methods:A retrospective analysis was conducted on the clinical data of 30 patients with recurrent cervical cancer with isolated lesions in the radiated field who underwent CT guided percutaneous interstitial implantation for close range radiation treatment at Zhengzhou University Affiliated Cancer Hospital from March 2023 to August 2024. Under local anesthesia, a needle was implanted into the recurrent tumor in the pelvic or abdominal wall of the patients percutaneously guided by CT. The target area was delineated to ensure full dose coverage. The prescribed dose for high-risk clinical target areas was 600 cGy/time, once a week, followed by close range radiotherapy. The number of implanted needles were recorded, and the target area, radiation dose, and other parameters were evaluated through dose volume parameter maps. The degree of lesion shrinkage and the occurrence of complications during and after treatment were observed.Results:30 patients underwent a total of 72 rounds of brachytherapy with implantation, with a technical success rate of 100% (72/72). 20 cases received 2 treatments, 8 cases received 3 treatments, and 2 cases received 4 treatments; 4 cases used 1needle, 20 cases used 2 needles, 4 cases used 3 needles, and 2 cases used 4 needles. The high-risk clinical target dose D 90 was (718.17±222.61) cGy. The average dose D 2cc of 2 cm 3 surrounding the bladder, rectum, sigmoid colon, and small intestine was (168.29±53.80) cGy, (178.87±105.38) cGy, (136.05±78.06) cGy, and (288.91±117.49) cGy, respectively. The median follow-up time was 11 months. Among the 30 patients, there were 12 cases of complete remission,14 cases of partial remission, 3 cases of stable disease, and 1 case of disease progression, with an objective remission rate of 86.7%. None of the patients experienced significant bleeding or pain during treatment. After treatment, 3 patients with recurrent lymph nodes near the rectum developed grade 1 radiation proctitis, which was remitted after treatment. No significant complications were observed in the remaining patients. Conclusion:CT guided percutaneous brachytherapy is safe and feasible for the recurrence of single lesions in the radiated field of cervical cancer.

Objective:To prepare ((2-(2-chlorophenyl)-3-(4-((2- 18F-fluoroethyl)oxy)phenyl)-5, 6, 7, 8-tetrahydrooxepino[3, 2-c]pyrazol-8-yl)amino)methanoic acid methyl ester ( 18F-JR-1001) and evaluate its binding affinity to the cannabinoid type 1 receptor (CB1R). Methods:18F-JR-1001 was synthesized using an integrated automated synthesis module, and its radiochemical yield (RCY) and molar activity were determined. Cell-specific uptake, lipid-water partition coefficient (log P), competitive binding assays, and in vitro stability tests were performed. Rimonabant-fed rat models (blocking group) with pre-occupied CB1R were established. Radioautography and microPET/CT imaging were conducted on both the blocking group and normal Sprague-Dawley (SD) rats to evaluate the brain uptake of 18F-JR-1001 and its blood-brain barrier (BBB) penetration capability. Results:The RCY of the synthetic 18F-JR-1001 after decay correction was (32.5±9.2)% ( n=10), with the molar activity of (194.6±67.3)GBq/μmol. Cell experiments demonstrated that 18F-JR-1001 exhibited specificity for CB1R, with log P of 3.40±0.11 ( n=3) and half-maximal inhibitory concentration of 0.975nmol/L. Within 3h at 37℃, the radiochemical purity of 18F-JR-1001 in physiological saline and blood remained above 92%, with no significant radioactive by-product peaks observed. Radioautography showed that the whole brain uptake of 18F-JR-1001 in the blocking group was 65.6% of that in normal SD rats. MicroPET/CT imaging showed that the mean whole brain uptake of 18F-JR-1001 in the blocking group was 0.4706, which was lower than that in normal SD rats (1.0561). Additionally, continuous scanning for 60min demonstrated that 18F-JR-1001 exhibited good BBB penetration capability. Conclusion:The synthesized 18F-JR-1001 meets the requirements of production and application, and is proved the potential as a CB1R-targeted tracer in the in vitro experiments, microPET/CT imaging and radioautography.

Objective:To identify factors influencing treatment-free remission (TFR) outcomes in children and adolescent patients with chronic myeloid leukemia (CML) after imatinib (IM) discontinuation.Methods:This multicenter retrospective study analyzed 36 children and adolescent patients with CML from eight hematology centers in China (December 1, 2016, to September 27, 2024) who discontinued IM therapy with documented post-cessation outcomes. Clinical characteristics and molecular response dynamics were assessed. Univariate analysis and multivariate Cox proportional hazards regression models were employed to assess factors associated with TFR outcomes.Results:A total of 36 patients were documented, comprising 17 males and 19 females. The median ages at CML diagnosis and IM discontinuation were 11 years ( IQR: 5,16) and 20 years ( IQR: 14,25), respectively. The median time from IM initiation to first deep molecular response (DMR) was 21 months ( IQR: 13, 38). Pre-discontinuation, patients received IM for a median duration of 96 months ( IQR: 84, 121) and maintained DMR for 74 months ( IQR: 63, 89). With a median post-discontinuation follow-up of 38 months ( IQR: 15, 68), cumulative TFR rates at 6, 12, 24, and 36 months were 74.1%, 60.7%, 60.7%, and 56.0%, respectively, generating an overall TFR rate of 58.3%. Fifteen patients lost major molecular response at a median of 5 months post-discontinuation ( IQR: 3, 11). All 15 patients resumed tyrosine kinase inhibitor therapy, comprising 13 who restarted IM and 2 who switched to dasatinib. By the last follow-up, 13 (86.7% ) patients regained DMR after a median treatment duration of 5 months ( IQR: 3, 17), and no disease progression occurred in any patient. Withdrawal syndrome occurred in 2 (5.6% ) patients. Univariate analysis revealed significantly higher TFR rates in patients with pre-discontinuation IM duration of ≥100 months vs <100 months (82.4% vs 36.8%, P=0.017) and pre-discontinuation DMR duration of ≥72 months vs <72 months (84.2% vs 29.4%, P=0.003). Multivariate Cox analysis identified pre-discontinuation DMR duration as an independent protective factor for TFR ( HR=5.419, 95% CI: 1.524–19.272, P=0.009) . Conclusion:DMR duration was identified as an independent protective factor influencing TFR outcomes in children and adolescent patients with CML after IM discontinuation. Patients who maintained DMR for ≥72 months before IM discontinuation demonstrated a significantly higher TFR rate.

Objective: To understand the smoking-related behaviors and influencing factors of current smoking among medical staff in Fengtai District, Beijing Municipality, so as to provide the reference for reducing the current smoking rate of medical staff. Methods: Medical staff in 28 medical and health institutions in Fengtai District were selected as the survey subjects from February to March and July to August 2023. Basic information, smoking and smoking cessation behaviors, and the provision of brief smoking cessation intervention services were collected through electronic questionnaires. Factors affecting current smoking among medical staff were analyzed using a multivariable logistic regression model. Results: Totally 6 716 questionnaires were allocated, and 6 714 valid questionnaires were recovered, with an effective recovery rate of 99.97%. There were 1 590 males (23.68%) and 5 124 females (76.32%). There were 3 315 medical staff in clinical department, accounting for 49.37%. There were 457 current smokers and the current smoking rate among medical staff was 6.81%. The proportion of medical staff in clinical departments who were current smokers and provided brief smoking cessation intervention services was 72.99%, which was lower than that of non-current smokers at 85.18% (P<0.05). Multivariate logistic regression analysis showed that medical staff in secondary and above hospitals (OR=1.454, 95%CI: 1.136-1.862), male (OR=51.158, 95%CI: 34.810-75.183), work experience of 10~<20 years (OR=1.492, 95%CI: 1.065~2.092) or ≥30 years (OR=1.574, 95%CI: 1.011~2.449), those with positions (OR=1.644, 95%CI: 1.159-2.332), and those in logistics departments (OR=2.124, 95%CI: 1.278-3.528) or other departments (OR=2.011, 95%CI: 1.297-3.118) had a higher likelihood of being current smokers. On the contrary, medical staff with a bachelor's or junior college education level (OR=0.487, 95%CI: 0.346-0.685) or a master's degree or above (OR=0.268, 95%CI: 0.159-0.454), and those with an intermediate professional title (OR=0.430, 95%CI: 0.291-0.636) or a senior professional title (OR=0.452, 95%CI: 0.283-0.723) had a lower likelihood of being current smokers. A total of 214 medical staff successfully quit smoking, and the smoking cessation rate was 31.89%. Among them, 20, 18, and 17 medical staff had used the smoking cessation service hotline, visited smoking cessation clinics, and taken smoking cessation medications, respectively. In the past year, 199 medical staff who were current smokers (43.54%) had attempted to quit smoking, and 280 medical staff who were current smokers (61.27%) had the willingness to quit smoking. Conclusions The current smoking rate among medical staff in Fengtai District is relatively high. Hospital level, gender, educational level, work experience, position, professional title, and department are influencing factors for current smoking among medical staff. It is necessary to enhance the willingness of medical staff to quit smoking and their understanding of smoking cessation intervention services, so as to reduce the current smoking rate.

Objective To explore the relationship between serum S100 calcium-binding protein(S100)A4,S100A12 and the infection type and prognosis of neonatal infectious pneumonia(NIP).Methods A total of 300 children with NIP admitted to the Neijiang Second People's Hospital from January 2021 to March 2024 were selected and divided into the bacterial infection group(214 cases)and the non-bacterial infection group(86 cases)according to the types of pathogenic bacteria.Another 150 healthy newborns in the same hospital during the same period were selected as the control group.The levels of serum S100A4 and S100A12 were de-tected by enzyme-linked immunosorbent assay.Pearson correlation analysis was conducted to examine the cor-relations between serum S100A4,S100A12 and procalcitonin(PCT),white blood cell count(WBC),albumin(Alb),and platelet count(PLT).The receiver operating characteristic(ROC)curve was used to evaluate the differential value of serum S100A4,S100A12,PCT,WBC,Alb,and PLT alone and in combination for NIP bac-terial infection.According to the prognosis,children with NIP were divided into the poor prognosis group(63 cases)and the good prognosis group(237 cases).Multivariate Logistic regression model was used to analyze the influencing factors of poor prognosis in children with NIP,and ROC curve was used to analyze the value of each factor in predicting poor prognosis in children with NIP.Results The levels of serum S100A4,S100A12,PCT,WBC,and PLT in the bacterial infection group were higher than those in the non-bacterial infection group and the control group,while Alb was lower than that in the non-bacterial infection group and the control group,the differences were statistically significant(P<0.05).Pearson correlation analysis showed that serum S100A4 and S100A12 in children with NIP were positively correlated with PCT,WBC and PLT(P<0.05),and negatively correlated with Alb(P<0.05).The results of ROC curve analysis showed that the area under the curve(AUC)of serum S100A4 and S100A12 in differentiating NIP infection types was slightly lower than that of PCT,WBC,Alb,and PLT in differentiating NIP infection types.The results of multivariate Logistic re-gression analysis showed that elevated S100A4,elevated S100A12,elevated PCT,bacterial infection,and lung consolidation were independent risk factors for poor prognosis in children with NIP(P<0.05).The AUC of bacterial infection,lung consolidation,PCT,S100A4,and S100A12 for predicting the poor prognosis of chil-dren with NIP was 0.903.It was greater than the AUC predicted separately by bacterial infection,lung consol-idation,PCT,S100A4,and S100A12 levels(Z=9.989,9.460,5.514,4.084,4.376,P<0.001).Conclusion The combination of serum S100A4 and S100A12 with traditional markers has certain discrimina-tory value for the infection types of NIP,and the levels of serum S100A4 and S100A12 are related to the prog-nosis of NIP.

With the progress of medical insurance reform,the refinement of medical insurance management in pub-lic hospitals still fails to meet the actual demands for medical insurance work.Based on the existing problems of medical insurance management,it emphasizes the necessity of the refined management of medical insurance.By integrating be-havioral economics theory,it divides the refined management of medical insurance into five distinct stages:develop-ment planning,process-oriented platform,organizational framework,staff training programs and regulatory supervi-sion.The behavioral logic of the refined management of medical insurance in public hospitals is analyzed.Building on this analysis,the relevant key insights are summarized to provide a reference for promoting the public welfare-oriented reform of public hospitals and realizing the high-quality development of public hospitals.

Objective:To investigate the effects of tetramethylpyrazine(TMP)on spinal cord inflammation and phosphatidylinositol 3-kinase/serine-threonine kinase/nuclear factor-κB(PI3K/Akt/NF-κB)signaling pathway in rats with lumbar disc herniation(LDH).Methods:The rats were divided into Control group,lumbar disc herniation group(LDH group),TMP low-dose,high-dose group(TMP-L,TMP-H group),TMP high-dose+PI3K inhibitor group(TMP-H+LY294002 group)by random number table method.LDH rat model was established by autologous nucleus pulposus transplantation and treated with corresponding drugs.After administration,the pain threshold of rats in each group was measured by paw tactile tester and plantar thermal stimulation tester.Hematoxylin-eosin(HE)staining was used to observe the histomorphological changes of dorsal root ganglion.Enzyme linked immunosorbent assay(ELISA)was used to measure the levels of tumor necrosis factor α(TNF-α),interleukin-1β(IL-1β)and interleukin-6(IL-6)in the spinal dorsal horn.Immunohistochemistry was used to detect the expression of ionized calcium binding adapter molecule 1(Iba-1)and c-Fos in the spinal dorsal horn.Western blot was used to detect the expression of PI3K/Akt/NF-κB signaling pathway related proteins,and the ratios of p-PI3K/PI3K,p-Akt/Akt and p-NF-κB p65/NF-κB p65 were calculated.Results:At 24h before intervention,the paw withdrawal mechanical threshold(PWMT)and paw withdrawal thermal latency(PWTL)in the LDH group were lower than those in the Control group(P<0.05).At 24h after intervention,compared with Control group,the LDH group had severe nucleus deviation,blurred nucleoli,large amount of inflammatory cell infiltration and obvious cell swelling,decreased PWMT,PWTL,p-PI3K/PI3K and p-Akt/Akt,and increased levels of TNF-α,IL-1β,IL-6 and Iba-1,c-Fos and p-NF-κB p65/NF-κB p65(P<0.05).Com-pared with the LDH group,the neurons had less nuclear deviation,clearer nucleoli,less cell swelling and inflammatory cell infiltration in the TMP-L group and TMP-H group,and the PWMT,PWTL,p-PI3K/PI3K and p-Akt/Akt were in-creased in turn,while the levels of TNF-α,IL-1β,IL-6 and Iba-1,c-Fos,p-NF-κB p65/NF-κB p65 were decreased in turn(P<0.05).Compared with the TMP-H group,the TMP-H+LY294002 group had more severe pathological dam-age of neurons,obvious nuclear deviation,blurred nucleoli,cell swelling and inflammatory cell infiltration,decreased PWMT,PWTL,p-PI3K/PI3K and p-Akt/Akt,and increased levels of TNF-α,IL-1β,IL-6 and Iba-1,c-Fos and p-NF-κB p65/NF-κB p65(P<0.05).Conclusion:TMP can inhibit the activation of microglia and the expression of Iba-1 and c-Fos,and improve spinal cord inflammation in LDH rats,and its mechanism may be related to the regulation of PI3K/Akt/NF-κB signaling pathway.

Objective:To investigate the effects of tetramethylpyrazine(TMP)on spinal cord inflammation and phosphatidylinositol 3-kinase/serine-threonine kinase/nuclear factor-κB(PI3K/Akt/NF-κB)signaling pathway in rats with lumbar disc herniation(LDH).Methods:The rats were divided into Control group,lumbar disc herniation group(LDH group),TMP low-dose,high-dose group(TMP-L,TMP-H group),TMP high-dose+PI3K inhibitor group(TMP-H+LY294002 group)by random number table method.LDH rat model was established by autologous nucleus pulposus transplantation and treated with corresponding drugs.After administration,the pain threshold of rats in each group was measured by paw tactile tester and plantar thermal stimulation tester.Hematoxylin-eosin(HE)staining was used to observe the histomorphological changes of dorsal root ganglion.Enzyme linked immunosorbent assay(ELISA)was used to measure the levels of tumor necrosis factor α(TNF-α),interleukin-1β(IL-1β)and interleukin-6(IL-6)in the spinal dorsal horn.Immunohistochemistry was used to detect the expression of ionized calcium binding adapter molecule 1(Iba-1)and c-Fos in the spinal dorsal horn.Western blot was used to detect the expression of PI3K/Akt/NF-κB signaling pathway related proteins,and the ratios of p-PI3K/PI3K,p-Akt/Akt and p-NF-κB p65/NF-κB p65 were calculated.Results:At 24h before intervention,the paw withdrawal mechanical threshold(PWMT)and paw withdrawal thermal latency(PWTL)in the LDH group were lower than those in the Control group(P<0.05).At 24h after intervention,compared with Control group,the LDH group had severe nucleus deviation,blurred nucleoli,large amount of inflammatory cell infiltration and obvious cell swelling,decreased PWMT,PWTL,p-PI3K/PI3K and p-Akt/Akt,and increased levels of TNF-α,IL-1β,IL-6 and Iba-1,c-Fos and p-NF-κB p65/NF-κB p65(P<0.05).Com-pared with the LDH group,the neurons had less nuclear deviation,clearer nucleoli,less cell swelling and inflammatory cell infiltration in the TMP-L group and TMP-H group,and the PWMT,PWTL,p-PI3K/PI3K and p-Akt/Akt were in-creased in turn,while the levels of TNF-α,IL-1β,IL-6 and Iba-1,c-Fos,p-NF-κB p65/NF-κB p65 were decreased in turn(P<0.05).Compared with the TMP-H group,the TMP-H+LY294002 group had more severe pathological dam-age of neurons,obvious nuclear deviation,blurred nucleoli,cell swelling and inflammatory cell infiltration,decreased PWMT,PWTL,p-PI3K/PI3K and p-Akt/Akt,and increased levels of TNF-α,IL-1β,IL-6 and Iba-1,c-Fos and p-NF-κB p65/NF-κB p65(P<0.05).Conclusion:TMP can inhibit the activation of microglia and the expression of Iba-1 and c-Fos,and improve spinal cord inflammation in LDH rats,and its mechanism may be related to the regulation of PI3K/Akt/NF-κB signaling pathway.